Abiopharma

🔍 Cole Matthew Ryan (Director)

Company: Strive, Inc. (ASST)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 702,856 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 702,856.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: The Restricted Stock Units vest as follows: 20% vests on each of the first five anniversaries of the applicable vesting commencement date (with the vesting dates always being on September 12 of each year), in all cases subject to the Reporting Person's continued employment through each applicable vesting date.